CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 10 No. 10
 

BOOK REVIEW: Changing the Odds: Cancer Prevention Through Personal Choice and Public Policy

Reviewed by Douglas L. Weed, MD, PhD
National Cancer Institute, Bethesda, Maryland

| October 1, 1996


The premise of Steen's book is that nearly everyone is confused about cancer prevention. The public, for whom the book is written, is the most confused, but cannot be faulted. According to Steen, the responsibility for their confusion lies with scientists and the press. Scientists make mistakes by reporting preliminary data from inadequate and mostly "workmanlike, undistinguished" (page 3) studies. The press, in turn, repeats these mistakes, adds some of its own, and so oversimplifies a complex topic that the public, in the end, receives "unconnected facts, partial truths, and outright lies" (page 3).

To this morass of disinformation, Steen brings his solution. He will sort out the risks by reviewing what the jacket cover describes as "over 2,000 primary sources and references." After presenting evidence and ranking over 200 different risks, Steen recommends to the confused public what course they can take to prevent cancer.

It is a noble task, and Steen should not be faulted for trying to accomplish it. For some long-accepted prevention messages, Steen is right on the mark. Smoking is responsible for many cancers and deserves emphasis. Unfortunately, Steen's thesis is not well supported by this example: The public is not likely confused about the dangers of smoking; it is a public health message now 30 years old. The point is that we should not criticize Steen for reciting the obvious, nor can we evaluate his book on this basis. Rather, we must evaluate it on the greater task--the selection and review of evidence, the ranking of factors, and the recommendation of strategies--keeping in mind that Steen has criticized scientists and the press for failing to carry out their responsibilities.

My first concern relates to the strategy by which Steen has selected evidence. He has chosen a tiny fraction of the studies published on topics without informing the reader of the process that he used to make those selections. Consider for example, the association between smoking and cervical cancer. From 1966 through 1995, 39 case-control studies, 5 cohort studies, 10 comprehensive reviews, 2 meta-analyses, and at least a dozen studies of biologic parameters have been published. From these 70 publications, Steen selects 2: a case-control study showing a positive effect and a clinical study showing that, in smokers, nicotine(Drug information on nicotine)--a marker of exposure--reaches the cervical epithelium. Although the results of these two studies coincide with the accepted public health notion that smoking is unhealthy, there is no consensus in the scientific community on whether smoking has an independent causal role in the etiology of cervical cancer.

This example brings up an important concern: to what extent has Steen accurately represented the current status of scientific thinking on the other 200 topics included in his book? The public has no way of knowing.

The ranking process used in the book is also troublesome. Steen uses the size of the P value as his measure of validity, thus ignoring the more likely challenge; namely, confounding. Steen also groups cancers by incidence, and uses the group number (1 through 5) as a multiplier applied to the relative risk from the study with the smallest P value to provide the ranking number. But prostate and bladder cancers are grouped together (group #4) despite the fact that the incidence of prostate cancer (132,000 cases) is much closer to that of colon cancer in group #5 (156,000 cases) than it is to bladder cancer (51,600 cases) in group #4, which, itself, is much closer to uterine cancer (45,500 cases) in group #3. The result is a ranking of risks that is nearly as arbitrary as the group cut-off points themselves.

A Frustrating List

Perhaps most frustrating, however, is the fact that Steen's final list of risk factors for preventable cancers (page 269) and his list of "what to do" to prevent those cancers do not match up. He describes several strategies (pages 273 and 274), from stopping smoking to learning the 10 warning signs of cancer, but ignores at least 9 items listed earlier as preventable risks. These include: exposure to DDT, stress, use of oral contraceptives, eating more carbohydrates, eating fewer calories, having children, and exposure to black hair dyes. All were identified by Steen's method of selecting evidence and his ranking scheme.

It is unclear why these items were not transferred from the list of risks to the list of preventive strategies. Perhaps some do not offer preventive promise. If so, then it is reasonable to question the way in which they were identified. On the other hand, perhaps Steen simply overlooked them or made some other unspecified judgment regarding their validity or reasonableness. In either case, this book provides the public--for whom it was written--with one more reason to be confused about what should be done to prevent cancer.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy